These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 34616734)

  • 1. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
    Ping L; Zhang K; Ou X; Qiu X; Xiao X
    Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
    [No Abstract]   [Full Text] [Related]  

  • 2. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer.
    Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J
    Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433
    [No Abstract]   [Full Text] [Related]  

  • 3. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pyroptosis-related lncRNA signature in bladder cancer.
    Wang P; Wang Z; Zhu L; Sun Y; Castellano L; Stebbing J; Yu Z; Peng L
    Cancer Med; 2023 Mar; 12(5):6348-6364. PubMed ID: 36237132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
    Zhou W; Zhang W
    BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
    Front Genet; 2022; 13():838624. PubMed ID: 35928454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma.
    Wang P; Wang Z; Lin Y; Castellano L; Stebbing J; Zhu L; Peng L
    Mol Biotechnol; 2024 Feb; 66(2):332-353. PubMed ID: 37154865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J; Liang Y; Gu JJ; Huang Y; Wang B
    Front Genet; 2022; 13():991162. PubMed ID: 36353118
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer.
    Yang X; Weng X; Yang Y; Jiang Z
    Front Genet; 2021; 12():792106. PubMed ID: 35360412
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer.
    Gao SC; Wu MD; Zhang XX; Liu YF; Wang CL
    Asian J Surg; 2023 Sep; 46(9):3529-3541. PubMed ID: 37330302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma.
    Gong Z; Li Q; Yang J; Zhang P; Sun W; Ren Q; Tang J; Wang W; Gong H; Li J
    Front Bioeng Biotechnol; 2022; 10():852734. PubMed ID: 35646872
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer.
    Zhang Z; Xu Z; Yan Y
    Front Med (Lausanne); 2021; 8():793515. PubMed ID: 35096881
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.
    Liu ZK; Wu KF; Zhang RY; Kong LM; Shang RZ; Lv JJ; Li C; Lu M; Yong YL; Zhang C; Zheng NS; Li YH; Chen ZN; Bian H; Wei D
    Front Oncol; 2022; 12():794034. PubMed ID: 35311105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of prognostic signature of patients with oral squamous cell carcinoma based on pyroptosis-related long non-coding RNAs.
    Xin Y; Zhang J; Jiang Q; Qiu J
    Front Surg; 2022; 9():935765. PubMed ID: 36211292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
    Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.
    Lu Z; Tang F; Li Z; Lai Y; Lu Z; Zhang J; Tang Z; Cai W; He Z
    Dis Markers; 2022; 2022():7931393. PubMed ID: 35154513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.